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ABSTRACT 
Objective: The present study was aimed to investigate safety evaluation studies of methanolic stem extract of A. indica (AIS-ME) through acute and 
sub-chronic toxicity studies in albino wistar rats.  
Methods: Acute toxicity test was carried out in albino wistar rats by single dosage administration of 500, 1000 and 1500mg/kg body weight of AIS-
ME and observed for mortality and behavioural changes for a period of 24h. Sub-chronic toxicity studies were conducted by an oral administration 
of 100mg/kg body weight AIS-ME in albino wistar rats for a period of 30 consecutive days. Rats in sub-chronic toxicity studies were checked for 
body weight once in a week for 30 days and at the end of the experimental period, blood samples were collected for hematological and biochemical 
parameters. Organs (Liver and Kidney) were harvested and histological sections were made to examine for any organ damage after the treatment of 
AIS-ME. 
Results: Acute toxicity study resulted in no mortality and behavioural changes even at the post oral dosage of 1500mg/kg body weight of AIS-ME. 
Sub-chronic toxicity revealed no significant changes in body weight, hematological and biochemical parameters of treated groups in comparision 
with the control groups. Histological sections of treated groups resulted in similar architecture as that of nomal groups suggesting no morphological 
damages of the internal organs.  
Conclusion: This study concluded that AIS-ME is non toxic as per the results of acute and sub-chronic toxicity studies. Thus, it could be considered 
as a safe phytomedicine for oral administration in experimental rats. 
Keywords: A. indica, Safety evaluation studies, Albino wistar rats.  
 
INTRODUCTION 
Acalypha indica is commonly known as Indian copper leaf belongs to 
the family Euphorbiaceae is an erect annual weed plant growing to a 
height of 60 cm. It grows extensively in most of the regions of Asian 
continent including India, Pakistan, Yemen, southern districts of 
China and South Africa [1,2]. Stems are longitudinally ribbed and 
pubescent. Leaves are ovate with toothed margins except near the 
base. Flowers are unisexual with axillary spikes. Fruits are 
tuberculate, three lobed and pubescent. The whole plant of A. indica 
is used in traditional medicine system to treat various diseases. In 
Ayurveda, A. indica used as a laxative, antihelmintic, emetic, 
expectorant and also used to treat scabies, earache, syphilitic ulcers 
and snake bites [3]. In Siddha medicine, A. indica is used to treat 
diseases associated with teeth and gums, stomach ache, irritations, 
burns, wheezing and respiratory diseases [4].  
A. indica has been studied for various pharmacological activities in 
experimental animals namely, antidiabetic [5], wound healing [6], 
postcoital antifertility [7], anti snake venom [8], analgesic and 
antipyretic activities [9]. Many phytochemical compounds have been 
isolated from A. indica. The whole plant of A. indica contains 
saponins and alkaloids [10]. Acalyphamide was isolated from the 
roots of A. indica [11]. Cyanogenic and noncyanogenic glycosides 
were isolated from the leaves and twigs of A. indica [12].  
Kaempferol glycosides (mauritianin, clitorin, nicrotiflorin, biorobin) 
were isolated from the leaves of A. indica [13]. These plants as a 
whole or its parts were used widely as phytomedicine in tropical 
and subtropical countries. Toxicity evaluation studies are most 
important for the safe consumption of herbal medicine at selected 
dosages by initial testing of the herbal extracts in experimental rats 
with many trials considering the biosafety of humans. However, to 
the best of our knowledge, there is no report for in vivo 
pharmacological activities as well as safety evaluation studies on the 
methanolic stem extract of A. indica (AIS-ME). Hence, the present 
study was aimed to investigate acute and sub-chronic toxicity 
studies of methanolic stem extract of A. indica. 
 
 
Fig. 1: Photograph of medicinal plant Acalypha indica Linn. 
 
MATERIALS AND METHODS 
Plant material and method of extraction 
Acalypha indica stems were collected in fresh condition from 
Seshachalam forest area (40°35′02″N79°43′19″N), Chittoor district, 
Andhra Pradesh, India. The herbarium of the plant was 
authenticated by Dr. P. Jayaraman, Director, Institute of herbal 
botany, Plant Anatomy Research Centre (PARC), Chennai with 
reference no. PARe/2013/2146. Stems were shade dried, pulverized 
into powder and were extracted using methanol in Soxhlet 
apparatus. Thus obtained methanolic stem extract of A. indica (AIS-
ME) was concentrated in the rotary evaporator at 40°C under 
reduced pressure (72 mbar) to completely evaporate methanol from 
the extract, lyophilized and stored in air tight container at 4°C in a 
refrigerator. 
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Animals used for the study 
Adult albino wistar rats of either sex (150-200 g) were acquired 
from Animal house, Centre for Biomedical Research, SBST, VIT 
University, Vellore. Animals were maintained in a room at 20°C with 
12 h light to dark cycle and fed with standard rodent diet obtained 
from Hindustan Lever Ltd (Mumbai, India) and had access to water 
ad libitum. The experimental protocols were approved by the ethical 
committee in accordance with institutional animal ethical 
committee, 1333/C/10/CPCSEA. 
Acute toxicity studies 
Acute toxicity test was performed as per the protocol recommended 
by the World Health Organization for the evaluation of safety and 
efficacy of herbal medicines [14]. Twenty albino wistar rats were 
divided into four groups of five animals in each group. Group 1 served 
as a normal control. Group 2, 3 and 4 served as treated groups and 
received 500, 1000 and 1500 mg/kg body weight of AIS-ME 
respectively. Behavioral changes, symptoms of toxicity and mortality 
were observed after 24 h of oral administration of the AIS-ME. 
Sub-chronic toxicity studies 
Sub-chronic toxicity test was performed as per the guidelines of the 
World Health Organization for the evaluation of safety and efficacy 
of herbal medicines [14]. Twenty albino wistar rats were divided 
into four groups of five animals in each group. Group 1 and group 3 
received saline and considered as control males and control females. 
Group 2 and group 4 were orally administered with 100mg/kg body 
weight of AIS-ME was considered as test males and test females. 
Each animal in the four groups received oral administration 
everyday for a period of 30 days. 
Clinical observations 
Each animal in the four groups was observed for the abnormalities, 
physical appearance and mortality. 
Body weight 
Body weight of each animal in the four groups was measured using 
an electronic weighing balance at the time of acclimatization, once 
before starting the experiment, weekly once during the 
experimental period and at the sacrifice after fasting the animals. 
Clinical pathology 
Animals fasted overnight were euthanized on 30th day. Blood samples 
were collected from each group by cardiac puncture and transferred to 
heparinised and non heparinised centrifuge tubes. Heparinised blood 
samples of the animals in each group were tested for hematological 
parameters such as red blood cell count, white blood cell count, 
hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular 
hemoglobin concentration, Platelet distribution width and plateletcrit. 
Non-heparinised blood samples of the animals in each group were tested 
for biochemical parameters such as total cholesterol, high density 
lipoproteins, low density lipoproteins, very low density lipoproteins, 
triglyceride, serum glutamic pyruvic transaminase, serum glutamic 
oxaloacetic transaminase, alkaline phosphatase, total bilirubin and 
creatinine. Hematological and biochemical analysis was carried out using 
hematological and biological semi automatic analyzer (3000 Evolution, 
Tulip Group, India). 
Histopathology 
Animals in each group were sacrificed, kidneys and liver were 
dissected, washed using cold phosphate buffered saline and fixed in 
10% neutral buffered formalin for further histological analysis. 
RESULTS  
Acute toxicity study 
Acute toxicity study was initially conducted with a series of dosages 
(500, 1000 and 1500mg/kg body weight) to select the proper and 
safe dosage for sub-chronic toxicity study. In an acute toxicity study, 
there were no signs of mortality and behavioural changes even after 
the oral administration of 1500mg/kg body weight. The result of 
acute toxicity is tabulated (Table 1). 
Table 1: Effect of AIS-ME on mortality and behavioral changes 
on the rats in acute toxicity test 
Dose (mg/kg b. wt.)  Observations* 
Mortality (%) Behavioral changes 
 500  0.0 NAD* 
 1000  0.0 NAD* 
 1500  0.0 NAD* 
Observations were recorded after 24 h of extract administration and 
NAD: no abnormality detected.  
 
Sub-chronic toxicity study 
Sub-chronic toxicity studies were performed to check the overall 
toxicity of AIS-ME. During the period of experiment, there was no 
mortality in the treated as well as the control groups.  
Body weight 
Checking the body weight of the animals in the experimental period is an 
indicator of their normal growth because healthy animals cannot reduce 
10% of their initial body weight [15]. AIS-ME did not exhibit any 
significant changes in body weight of test males and test females in 
comparision with the control males and control females (Fig. 1).  
 
 
Fig. 2: Effect of AIS-ME on body weight in albino wistar rats. 
Values were expressed as Mean±SD of five animals (n=5) 
 
Hematological parameters 
There were no abnormalities in hematological parameters of tested 
groups of males and females to that of control males and control 
females (Table 2). 
Biochemical parameters 
Both AIS-ME treated groups and control groups exhibited normal 
levels of the biochemical parameters. Result of biochemical 
parameters is tabulated (Table 3). 
Histopathological analysis 
There was no inflammation, necrosis, hemorrhage or cellular 
abnormalities (deposits, degeneration, vacuoles etc.) in the test 
males and test females which were compared with the control males 
and control females (Fig. 2).  
 
Fig. 3: Effect of AIS-ME on Histopathological analysis 
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A & E - sections of kidney and liver from Male control group 
B & F - sections of kidney and liver from Male treated group 
C & G - sections of kidney and liver from Female control group 
D & H - sections of kidney and liver from Female treated group
 
Table 2: Effect of AIS-ME on hematological parameters in albino wistar rats 
Test Performed  Control males  Test males  Control females  Test females  
RBC (×106 7.346±0.13  /µl)  7.406±0.04  7.234±0.21  7.092±0.16  
WBC (×103 7.78±0.61  /µl)  7.71±0.79  8.494±1.01  9.294±0.28  
Plt (×103 455.8±14.1  /µl)  444±10.13  433±20.77  437±15.85  
HGB (g/dl)  12.6±0.71  12.4±0.92  11.84±0.49  11.66±0.82  
HCT (%)  35.1±2.08  32.6±0.81  33.12±0.64  33.38±1.82  
MCV (fL)  46.2±2.09  45.3±0.87  42.62±2.70  42.5±2.78  
MCHC (g/dl)  35.1±0.89  36.1±0.21  34.52±2.25  32.16±1.62  
PDW (%)  14.9±0.10  14.5±0.16  14.56±0.46  14.9±0.27  
PCT (%)  0.371±0.06  0.311±0.09  0.423±0.013  0.323±0.08  
RBC: Red blood cell, WBC: white blood cell, Plt: platelets, HGB: haemoglobin, HCT: hematocrit, MCV: mean corpuscular volume, MCHC: mean 
corpuscular haemoglobin concentration, PDW: Platelet distribution width, PCT: plateletcrit; Values were expressed as Mean±SD of five animals 
(n=5). 
 
Table 3: Effect of AIS-ME on biochemical parameters in albino wistar rats 
Test Performed  Control males  Test males  Control females  Test females  
TC (mg/dl)  71±3.87  68±4.13  74.6±6.65  70.4±6.65  
HDL (mg/dl)  62.8±5.11  60±6.19  58.6±7.70  63.2±5.58  
LDL (mg/dl)  23.2±2.01  19.1±1.20  19.68±1.33  17.46±1.76  
VLDL (mg/dl)  33.2±1.18  30.2±1.14  29.06±2.03  30.74±2.55  
TGL (mg/dl)  163±6.02  154.6±3.04  172±2.54  159.8±10.61  
SGPT (U/L)  47.8±2.23  39.2±2.79  44.4±4.84  39.02±1.48  
SGOT (U/L)  75.2±2.36  71.5±2.74  67.6±3.50  64.46±3.95  
ALP (U/L)  107.8±3.72  107.1±3.11  104±4.30  101±1.58  
TB (mg/dl)  1.11±0.18  1.03±0.15  1.08±0.08  0.942±0.04  
Creatinine (mg/ml)  1.01±0.09  0.95±0.09  1.054±0.07  0.972±0.05  
TC: total cholesterol, HDL: high density lipoproteins, LDL: low density lipoproteins, VLDL: very low density lipoproteins, TGL: triglyceride, SGPT: 
serum glutamic pyruvic transaminase, SGOT: serum glutamic oxaloacetic transaminase, ALP: alkaline phosphatase, TB: total bilirubin; Values were 
expressed as Mean±SD of five animals (n=5). 
 
DISCUSSION 
Plant derived drugs became popular worldwide for the prevention 
and treatment of various diseases. Globally, one hundred and 
nineteen secondary metabolites isolated from medicinal plants were 
used as phytomedicine in recent times. In India and other Asian 
countries, herbal medicine became a part for the regular 
management of their health [16]. Hence, safety evaluation studies 
are at most important which are carried out using experimental 
animals and thus providing guidelines to select safe dosages for 
human consumption as a phytomedicine. Acalypha indica gained 
popularity in both conventional and Western medicine because of 
having valuable phytochemical compounds within the herb [17]. In 
our previous study, AIS-ME was found to be rich in polyphenolic 
content and has shown promising antidiabetic and antioxidant 
activities [2]. Therefore this study was undertaken to evaluate the 
safety of AIS-ME through acute and sub-chronic toxicity studies. 
In acute toxicity study, there were no signs of mortality and 
behavioural changes even after the oral administration of 
1500mg/kg body weight which is the highest dosage than the 
regular doses used in the pharmacological experiments of A. indica 
such as antidiabetic [18], antiarthritic [19], wound healing activity 
[20], post-coital antifertility [7], analgesic and antipyretic activities 
[9]. Since there was no toxicity detected at 1500mg/kg body weight, 
LD50 
Sub-chronic toxicity studies were performed to check the overall 
toxicity of AIS-ME. Treatment dosage was selected based on the 
previous study on whole plant ethanolic extract of A. indica [21]. 
During the period of experiment, there was no mortality in the 
treated as well as control groups. Change in hematological 
parameters causes anemia which is an accompaniment of bone 
marrow toxicity [22]. There were no abnormalities detected in test 
males and test females in comparision with the control males and 
control females.  
value for A. indica is beyond 1500 mg/kg body weight, hence 
this study revealed the safety of AIS-ME upon acute administration 
for the pharmacological studies.  
Biochemical toxicity evaluation resulted in normal levels of 
cholesterol, triglycerides, high density, low density and very low 
density lipoproteins in male and female rats treated with AIS-ME as 
that of control groups. SGOT and SGPT act as biomarkers for the 
prediction of toxicity. Their levels are in normal range in the AIS-ME 
treated groups and also in the control groups. Normal level of 
creatinine indicates good renal function [23]. Raise in creatinine 
levels creates functional damage to nephrons. In the present study 
AIS-ME has shown no abnormalities in the biochemical parameters 
in comparision with the control groups. 
The organs harvested for histological analysis did not show any 
color and texture changes and were similar to that of control groups. 
Histopathological assessment of tissues collected from control and 
treated groups was carried for the evaluation of any systemic 
damage. In comparision with the control group, there were no 
abnormalities in the liver and kidney sections of male and female 
rats treated with AIS-ME.  
CONCLUSION 
In the light of the above findings, it can be concluded that the 
methanolic extract of A. indica is safe since it has not shown 
mortality and behavioural changes even after the oral 
administration of higher dosages in acute toxicity study. There was 
no reduction in the body weight of the treated animals as well as 
normal range of hematological and biochemical parameters 
throughout the sub-chronic toxicity evaluation study. Histological 
analysis of liver and kidney sections has shown normal architecture. 
Therefore, the methanolic extract of A. indica could be considered as 
safe for animal model experiments. Further, mutagenicity, 
carcinogenicity and teratogenecity studies have to be conducted for 
safe consumption of the extract by the human beings. 
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